These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 11717374)
21. Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Chou YH; Huang WS; Su TP; Lu RB; Wan FJ; Fu YK Eur Neuropsychopharmacol; 2007 Jan; 17(1):46-52. PubMed ID: 16842981 [TBL] [Abstract][Full Text] [Related]
22. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Itzhak Y; Ali SF Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090 [TBL] [Abstract][Full Text] [Related]
23. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438 [TBL] [Abstract][Full Text] [Related]
24. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594 [TBL] [Abstract][Full Text] [Related]
25. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632 [TBL] [Abstract][Full Text] [Related]
26. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Eisch AJ; O'Dell SJ; Marshall JF Synapse; 1996 Mar; 22(3):217-25. PubMed ID: 9132989 [TBL] [Abstract][Full Text] [Related]
27. Dopamine transporters decrease with age. Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Hitzemann R; Smith G; Fields SD; Gur R J Nucl Med; 1996 Apr; 37(4):554-9. PubMed ID: 8691238 [TBL] [Abstract][Full Text] [Related]
28. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528 [TBL] [Abstract][Full Text] [Related]
29. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269 [TBL] [Abstract][Full Text] [Related]
30. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
31. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum. Angulo JA; Angulo N; Yu J Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715 [TBL] [Abstract][Full Text] [Related]
32. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018 [TBL] [Abstract][Full Text] [Related]
33. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemann R; Ding YS; Pappas N; Shea C; Piscani K Alcohol Clin Exp Res; 1996 Dec; 20(9):1594-8. PubMed ID: 8986209 [TBL] [Abstract][Full Text] [Related]
34. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712 [TBL] [Abstract][Full Text] [Related]
35. Repeated amphetamine treatment causes a persistent elevation of glial fibrillary acidic protein in the caudate-putamen. Armstrong V; Reichel CM; Doti JF; Crawford CA; McDougall SA Eur J Pharmacol; 2004 Mar; 488(1-3):111-5. PubMed ID: 15044042 [TBL] [Abstract][Full Text] [Related]
36. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428. Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524 [TBL] [Abstract][Full Text] [Related]
37. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Volkow ND; Fowler JS; Wang GJ; Ding YS; Gatley SJ Eur Neuropsychopharmacol; 2002 Dec; 12(6):557-66. PubMed ID: 12468018 [TBL] [Abstract][Full Text] [Related]